CoreAge Rx vs FORM by GBY
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and FORM by GBY head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make FORM by GBY a bad call — it's best for people comparing clinician-reviewed injection, oral and branded-care pathways who confirm the specific plan, pharmacy charge and state eligibility. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | FORM by GBY |
|---|---|---|
| Brief Score | 94/100 (A) | 67/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Standard injection $99 first month; then $159 Compounded injection; exact selected supply/required fees unconfirmed. FORM3 blend $129 then $199; oral compounded plan $215/mo; Wegovy membership $95/mo is not a complete branded-drug quote. Excludes Alaska/Mississippi. Cancel or pause for end of current cycle; unused subscription time generally not refunded. Provider nonapproval is described as no charge. Full price detailsCompounded semaglutide weekly injection offered; complete selected-plan quote unknown; standard product $99 first month then $159, FORM3 blend $129 then $199; oral compounded product $215/month; Wegovy pill membership $95/month without a confirmed complete pharmacy price |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Standard injection $169 first month; then $219 Compounded injection; exact selected supply/required fees unconfirmed. FORM3 blend $199 then $299; Zepbound membership $95/mo is not a complete branded-drug quote. Excludes Alaska/Mississippi. Cancel or pause for end of current cycle; unused subscription time generally not refunded. Provider nonapproval is described as no charge. Full price detailsCompounded tirzepatide weekly injection offered; complete selected-plan quote unknown; standard product $169 first month then $219, FORM3 blend $199 then $299; Zepbound membership $95/month without a confirmed complete pharmacy price |
| Coverage | US only; restrictions by state, confirmed at intake | Terms and shipping page list 48 states plus Washington DC, excluding Alaska and Mississippi; clinician and pharmacy eligibility still apply |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
FORM by GBY: Standard semaglutide $99 then $159; tirzepatide $169 then $219. FORM3/oral/branded-care plans differ. Full selected quote unconfirmed; Alaska/Mississippi excluded; unused subscription time generally nonrefundable.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.